 |
 |
 |
 |
Biotron Limited is an Australian biotechnology company developing and commercializing novel therapeutics and diagnostics to address a range of significant health issues.
Biotron's current focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company has a number of early-stage projects targeting other indications such as cardiovascular disease.
RECENT ANNOUNCEMENTS
Underwriting Agreement - New Issue Announcement
Shareholder Update - May edition of BITNews
Quarterly Report 31 March 2008
Southern Cross Equities Report